Primary Site >> Colorectal Cancer
Gene >> FOXK2
| 1. | |||||||||||
| Journal: | Int J Cancer. 2012 Apr 1;130(7):1577-89. | ||||||||||
| Title: | Cetuximab +/- chemotherapy enhances dendritic cell-mediated phagocytosis of colon cancer cells and ignites a highly efficient colon cancer antigen-specific cytotoxic T-cell response in vitro. | ||||||||||
| Author: | Correale, P|Botta, C|Cusi, M G|Del Vecchio, M T|De Santi, M M|Gori Savellini, G|Bestoso, E|Apollinari, S|Mannucci, S|Marra, M|Abbruzzese, A|Aquino, A|Turriziani, M|Bonmassar, L|Caraglia, M|Tagliaferri, P | ||||||||||
| PMID: | 21618510 | ||||||||||
| 2. | |||||||||||
| Journal: | Biochem Biophys Res Commun. 2017 Jan 29;483(1):475-481. | ||||||||||
| Title: | Sox9 mediated transcriptional activation of FOXK2 is critical for colorectal cancer cells proliferation. | ||||||||||
| Author: | Qian, Yu|Xia, Suhua|Feng, Zhenyu | ||||||||||
| PMID: | 28007600 | ||||||||||
| 3. | |||||||||||
| Journal: | Onco Targets Ther. 2018 Feb 27;11:1067-1075. | ||||||||||
| Title: | Forkhead box K2 inhibits the proliferation, migration, and invasion of human glioma cells and predicts a favorable prognosis. | ||||||||||
| Author: | Wang, Bo|Zhang, XueBin|Wang, Wei|Zhu, ZhiZhong|Tang, Fan|Wang, Dong|Liu, Xi|Zhuang, Hao|Yan, XiaoLing | ||||||||||
| PMID: | 29520156 | ||||||||||